Ono swoops on Deciphera in $2.4 billion takeover

Japan’s Ono Pharma has bolstered its cancer pipeline with a $2.4 billion agreement to buy Deciphera Pharma of the US and its fast-growing gastrointestinal stromal tumour (

Trial flop busts Deciphera's blockbuster hopes for Qinlock

Shares in Deciphera Pharma went into freefall on Friday after top-line results of a phase 3 trial of its Qinlock in rare cancer gastrointestinal stromal tumour (GIST) dashed its hopes of mo

Blueprint pays the price of Ayvakit phase 3 miss as FDA reje...